Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| - | PE(38:3e)/PE(38:2p) | Lipid-depleted/compactin | 0.0 | BCD100322A02 | 67.3 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | Lipid-depleted/compactin | 0.5 | BCD100322A05 | 123 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | Lipid-depleted/compactin | 1.0 | BCD100322A09 | 101 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | Lipid-depleted/compactin | 2.0 | BCD100322A13 | 126 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | Lipid-depleted/compactin | 4.0 | BCD100322A17 | 136 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | Lipid-depleted/compactin | 8.0 | BCD100322A21 | 148 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | Lipid-depleted/compactin | 12.0 | BCD100322A25 | 117 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | Lipid-depleted/compactin | 24.0 | BCD100322A29 | 149 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | C | 0.0 | BCD100322A01 | 159 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | C | 0.5 | BCD100322A03 | 96 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | C | 1.0 | BCD100322A07 | 114 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | C | 2.0 | BCD100322A11 | 132 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | C | 4.0 | BCD100322A15 | 108 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | C | 8.0 | BCD100322A19 | 130 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | C | 12.0 | BCD100322A23 | 144 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | C | 24.0 | BCD100322A27 | 122 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100322A06 | 130 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100322A10 | 138 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100322A14 | 215 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100322A18 | 134 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100322A22 | 154 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100322A26 | 133 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100322A30 | 195 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | 25OH-Chol | 0.5 | BCD100322A04 | 85.7 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | 25OH-Chol | 1.0 | BCD100322A08 | 127 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | 25OH-Chol | 2.0 | BCD100322A12 | 136 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | 25OH-Chol | 4.0 | BCD100322A16 | 127 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | 25OH-Chol | 8.0 | BCD100322A20 | 145 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | 25OH-Chol | 12.0 | BCD100322A24 | 128 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | 25OH-Chol | 24.0 | BCD100322A28 | 183 | pmol/sample |